1,388 results on '"EGIDO, JESÚS"'
Search Results
2. A mutual regulatory loop between miR-155 and SOCS1 influences renal inflammation and diabetic kidney disease
3. Impact of renal function on the prognostic value of mineral metabolism in patients with chronic ischaemic heart disease patients with chronic ischaemic heart disease
4. Impacto de la función renal en el valor pronóstico del metabolismo mineral en pacientes con cardiopatía isquémica crónica
5. Cardiac Rehabilitation Increases Plasma Klotho Levels
6. Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease
7. Sickle cell nephropathy. Clinical manifestations and new mechanisms involved in kidney injury
8. Nefropatía falciforme. Manifestaciones clínicas y nuevos mecanismos implicados en el daño renal
9. Interleukin-17A: Potential mediator and therapeutic target in hypertension
10. Interleuquina-17A: posible mediador y diana terapéutica en la hipertensión
11. Initiation and titration of sacubitril/valsartan in different types of centers
12. The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
13. PCSK9 and HS-CRP Predict Progression of Aortic Stenosis in Patients with Stable Coronary Artery Disease
14. Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome
15. A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis
16. SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition
17. Fibroblast growth factor 23 independently predicts adverse outcomes after an acute coronary syndrome.
18. Intravascular hemolysis triggers NAFLD characterized by a deregulation of lipid metabolism and lipophagy blockade
19. TWEAK and RIPK1 mediate a second wave of cell death during AKI
20. Role of pyrophosphate in vascular calcification in chronic kidney disease
21. Combination of biomarkers of vascular calcification and sTWEAK to predict cardiovascular events in chronic kidney disease
22. Adverse effects of the renal accumulation of haem proteins. Novel therapeutic approaches
23. Efectos adversos de la acumulación renal de hemoproteínas. Nuevas herramientas terapéuticas
24. Potential Role of the mTORC1-PGC1α-PPARα Axis under Type-II Diabetes and Hypertension in the Human Heart
25. Fibroblast Growth Factor 23 is a strong independent marker of worse cardiovascular outcomes after an acute coronary syndrome
26. Differences between 2nd and 3rd generation seric parathormone determination methods on mortality in haemodialysis patients
27. Diferencias entre los métodos de determinación de 2.ª y 3.ª generación de la parathormona sérica sobre la mortalidad en el paciente en hemodiálisis
28. Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease
29. High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation
30. Interplay between HSP90 and Nrf2 pathways in diabetes-associated atherosclerosis
31. P-2 DE NOVO LIPOGENESIS MARKERS ARE INVOLVED IN METABOLIC ASSOCIATED FATTY LIVER DISEASE PROGRESSION IN BTBR OB/OB MICE
32. Potential role of the mTOR-C1-PGC1α-PPARα axis under type-II diabetes and hypertension in the human heart
33. Absence of High Lipoprotein(a) Levels Is an Independent Predictor of Acute Myocardial Infarction without Coronary Lesions
34. TWEAK/Fn14 System is Involved in Rhabdomyolysis-Induced Acute Kidney Injury
35. The pleiotropic effects of paricalcitol: Beyond bone-mineral metabolism
36. Efectos pleiotrópicos del paricalcitol, más allá del metabolismo óseo-mineral
37. Reduction in the risk of peripheral neuropathy and lower decrease in kidney function with metformin, linagliptin or their fixed-dose combination compared to placebo in prediabetes : a randomized controlled trial
38. Hemoglobin induces monocyte recruitment and CD163-macrophage polarization in abdominal aortic aneurysm
39. Preclinical Models
40. Sacubitril/Valsartan in Daily Clinical Practice: Data From a Prospective Registry
41. Gremlin, A Potential Urinary Biomarker of Anca-Associated Crescentic Glomerulonephritis
42. Use of sevelamer in chronic kidney disease: beyond phosphorus control
43. Impacto de los niveles plasmáticos de pro-péptido natriurético tipo B aminoterminal, proteína quimiotáctica de monocitos-1 y galectina 3 en la capacidad predictiva de eventos de la escala clínica LIPID en la enfermedad coronaria estable
44. Uso del sevelamer en la enfermedad renal crónica. Más allá del control del fósforo
45. La atorvastatina inhibe la progresión de la lesión aterosclerótica inducida por el factor inductor débil de apoptosis similar al factor de necrosis tumoral en ratones deficientes en apolipoproteína E
46. The Synthetic Flavonoid Hidrosmin Improves Endothelial Dysfunction and Atherosclerotic Lesions in Diabetic Mice
47. TLR4-mediated inflammation is a key pathogenic event leading to kidney damage and fibrosis in cyclosporine nephrotoxicity
48. Neutrophils play a key role in the initiation of glomerular hematuria in a postinfectious igan experimental model
49. Role of Toll‐like receptor 4 in intravascular hemolysis‐mediated injury
50. NT-proBNP Levels Influence the Prognostic Value of Mineral Metabolism Biomarkers in Coronary Artery Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.